Antigens & Antibodies
Showing 201–250 of 813 results
Human IgM Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6)
Recombinant humanized version of the neutralizing mouse monoclonal antibody MAB12444. Antibody is specific for SARS-CoV-2 receptor binding domain (RBD). The original monoclonal antibody (MAB12444) is neutralizing against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV.
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (AD10)
Recombinant humanized IgM version of the mouse monoclonal antibody MAB12446. Antibody is specific for SARS-CoV-2 spike subunit 2 (S2).
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (CH1)
Recombinant humanized IgM version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 (S2).
Human IgM Anti-Dengue Virus NS1 Serotype 1 Antibody (OB4)
Human IgM monoclonal antibody specific for Dengue virus serotype 1 NS1 (clone OB4).
Human IgM Anti-Flavivirus Envelope Protein Antibody (4G2)
Human IgM monoclonal antibody specific for flavivirus envelope protein (clone 4G2).
Human IgM Anti-SARS-CoV-2 Nucleoprotein Antibody (CR3009)
Human IgM anti SARS-CoV-2 nucleoprotein is a recombinant monoclonal antibody that recognizes and binds the non-linear/conformational epitope of the N protein of SARS-CoV and SARS-CoV-2. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human IgM Anti-SARS-CoV-2 Nucleoprotein Antibody (CR3018)
Human IgM anti SARS-CoV-2 nucleoprotein antibody (clone CR3018) is a recombinant monoclonal antibody that recognizes and binds the amino acid residues between 11-19 of the N protein of SARS-CoV and SARS-CoV-2. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human IgM Anti-SARS-CoV-2 Spike (S1) Antibody (CR3022)
Human IgM anti SARS-CoV-2 Spike antibody (CR3022) is a recombinant monoclonal antibody that recognizes the SARS-CoV and SARS-CoV-2 Spike glycoprotein, the causative agent of COVID-19. The antibody binds to both SARS-CoV and SARS-CoV-2 with high affinity at amino acids 318-510 (RBD, Receptor Binding Domain) in the S1 subunit of the Spike protein.
Human IgM Anti-Zika Virus NS1 Antibody (B4)
Human IgM monoclonal antibody specific for Zika virus NS1 (clone B4).
![Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade B (89BZ_167)]](https://thenativeantigencompany.com/wp-content/uploads/1970/01/Misc-Virus-33-M-1-300x300.jpg)
Human Immunodeficiency virus clade O, gp140 (SOSIP), untagged
HIV-1 clade O gp140 produced in HEK293 cells and purified from culture supernatant. The protein contains three amino acid substitutions I499C, I561P, Y606C. In addition, the furin cleavage site was enhanced from “RTHREKR” to “RRRRRR”. The furin processing is partial in HEK293 cells, and the prtoein is presented as a mix of cleaved and uncleaved protein.
Human Immunodeficiency Virus GP41 Protein [HIV-1/Clade B]
Recombinant HIV-1 [HIV-1/Clade B] gp41 protein with a His-tag. Manufactured in E. coli and
![Human Immunodeficiency Virus P24 Protein [HIV-1/Clade B]](https://thenativeantigencompany.com/wp-content/uploads/2020/01/Misc-Virus-168-300x300.jpg)
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade B]
Recombinant HIV p24 protein [HIV-1/Clade B] is produced in mammalian HEK293 cells and fused with a C-terminal 6xHis-tag.
Human immunodeficiency virus subtype A, gp140 (SOSIP), untagged
Human immunodeficiency virus subtype A. glycoprotein 140 (gp140). This protein is the soluble part of the human immunodeficiency virus Envelope protein gp160. An estimated 25% of the protein is cleaved into gp120 and the soluble gp41 fraction, 75% are presented as gp140. Oligomeric status is mainly monomeric, with a minority of dimer and trimer.
Human immunodeficiency virus subtype B, gp140 (SOSIP), untagged
Human immunodeficiency virus subtype B glycoprotein 140 (gp140). This protein is the soluble part of the human immunodeficiency virus Envelope protein gp160. An estimated 25% of the protein is cleaved into gp120 and the soluble gp41 fraction, 75% are presented as gp140. Oligomeric status is mainly monomeric, with a minority of dimer and trimer.
Human immunodeficiency virus subtype C, gp140 (SOSIP), untagged
This protein is the soluble part of the human immunodeficiency virus Envelope protein gp160. An estimated 25% of the protein is cleaved into gp120 and the soluble gp41 fraction, 75% are presented as gp140. Oligomeric status is mainly monomeric, with a minority of dimer and trimer.
Human immunodeficiency virus subtype CRF01_AE, gp140 (SOSIP), untagged
Human immunodeficiency virus subtype CRF01_AE glycoprotein 140 (gp140). An estimated 25% of the protein is cleaved into gp120 and the soluble gp41 fraction, 75% are presented as gp140. Oligomeric status is mainly monomeric, with a minority of dimer and trimer.
Human immunodeficiency virus type 2, gp140 (SOSIP), untagged
HIV-2 gp140 produced in HEK293 cells and purified from cultrue supernatant. The protein contains a C-terminal T4 foldon domain to stabilize natural trimers. The furin cleavage site was enhanced from "RHKR" to "RRRRRR" to facilitate furin cleavage. The protein is presented as a mix of cleaved and uncleaved protein.
Human Metapneumovirus (hMPV) 18 Type B2 Lysate
Human metapneumovirus 18 type B2 (Strain: IA18-2003) lysate from LLC-mk2 cell line. Purified by sucrose density gradient ultracentrifugation and heat-inactivated, followed by verification with validated tissue culture infectivity assay. Suitable for the development of immunoassays, Western blotting, dot blotting and other protein-based assays.
Human Metapneumovirus (hMPV) 3 Type B1 Lysate
Human metapneumovirus 3 type B1 (Strain: Peru2-2002) lysate from LLC-mk2 cell line. Purified by sucrose density gradient ultracentrifugation and heat-inactivated, followed by verification with validated tissue culture infectivity assay. Suitable for the development of immunoassays, Western blotting, dot blotting and other protein-based assays.
Human Metapneumovirus (hMPV) 9 Type A1 Lysate
Human metapneumovirus 9 type A1 (Strain: IA3-2002) lysate from LLC-mk2 cell line. Purified by sucrose density gradient ultracentrifugation and heat-inactivated, followed by verification with validated tissue culture infectivity assay. Suitable for the development of immunoassays, Western blotting, dot blotting and other protein-based assays.
Human Metapneumovirus (hMPV) A Glycoprotein G, His-Tag (HEK293)
Human metapneumovirus glycoprotein G ectodomain. The protein was produced in HEK293 cells and purified from culture supernatant. Glycoprotein G attaches the virion to the host cell membrane by interacting with glycosaminoglycans, initiating the infection. It also interacts with host DDX58 and inhibits DDX58-mediated signaling pathway in order to prevent the establishment of the antiviral state.
Human Metapneumovirus (hMPV) B Fusion Glycoprotein F0, His-Tag (HEK293)
Human metapneumovirus glycoprotein F0. The protein was produced in HEK293 cells and purified from culture supernatant. The F glycoprotein mediates virus-cell membrane fusion and is the primary target of neutralizing antibodies.
Human Metapneumovirus (hMPV) B Glycoprotein G, His-Tag (HEK293)
Human Metapneumovirus (hMPV) B glycoprotein G is a recombinant antigen produced in mammalian cells to Glycoprotein G attaches the virion to the host cell membrane by interacting with glycosaminoglycans, initiating the infection. It also interacts with host DDX58 and inhibits DDX58-mediated signaling pathway in order to prevent the establishment of the antiviral state.
Human Parainfluenza Virus Type 3 Lysate
Parainfluenza Virus Type 3 is purified from LLC-mk2 cells using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. Viral lysates can be utilized as an antigen, as a source for the purification of viral proteins, or for the detection of viral antibodies.
![Influenza B [B/Palermo/4/2013] Hemagglutinin Parainfluenza Virus Type 4A](https://thenativeantigencompany.com/wp-content/uploads/2020/12/Coronavirus-35-300x300.jpg)
Human Parainfluenza Virus Type 4A Lysate
Parainfluenza Virus Type 4A is purified from LLC-mk2 cells using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. Viral lysates can be utilized as an antigen, as a source for the purification of viral proteins, or for the detection of viral antibodies.
Human parainfluenzavirus 3 haemagglutinin-neuraminidase (HN) protein, C-terminal His-tag
Recombinant human Parainfluenza Virus Type 3 haemagglutinin-neuraminidase (HN) protein, manufactured in HEK293 cells.
Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) Envelope Protein, Sheep Fc-Tag (HEK293)
Recombinant human T-cell lymphotropic virus type 1 (HTLV-1) envelope protein. The protein was produced in HEK293 cells and purified to high purity from culture supernatant with a TEV cleavage site and C-terminal sheep Fc-tag.
Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) p24, C-terminal His-tag
HTLV-1 p24, C-terminal His-tag, purified by immobilized metal affinity chromatography, ion exchange chromatography and dialysis, Native Antigen.
Human T-Cell Lymphotropic Virus Type 2 (HTLV-2) Envelope Protein, Sheep Fc-Tag (HEK293)
Recombinant human T-cell lymphotropic virus type 2 (HTLV-2) envelope protein. The protein was produced in HEK293 cells and purified to high purity from culture supernatant with a TEV cleavage site and C-terminal sheep Fc-tag.
Human T-Cell Lymphotropic Virus Type 2 (HTLV-2) p24, C-terminal His-tag
Human T-lymphotropic virus 2 (HTLV-2) p24 gag protein produced in E. Coli. There is evidence for dimer and higher oligomer formation.
Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Hemagglutinin (HA), His-Tag
This recombinant hemagglutinin protein is derived from the HA sequence of the Influenza A/Cambodia/e0826360/2020 (H3N2)-like virus, expressing (AA) 1-547, and fused with a polyhistidine tag at the C-terminus. It was manufactured in mammalian HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Neuraminidase (NA), His-Tag
This recombinant neuraminidase protein is derived from the NA sequence of the Influenza A/Cambodia/e0826360/2020 (H3N2)-like virus, expressing aa 46-469, and fused with a polyhistidine tag at the C-terminus. It was manufactured in mammalian HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza A [A/Cambodia/NPH230032/2023] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Cambodia/NPH230032/2023] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/chicken/Scotland/054477/2021] Nucleoprotein (NP), HIS-TAG
Influenza A [A/chicken/Scotland/054477/2021)] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/Darwin/6/2021 (H3N2)-like virus] Hemagglutinin (HA), His-tag
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 northern hemisphere influenza season.
Influenza A [A/Darwin/6/2021 (H3N2)-like virus] Hemagglutinin (HA), His-tag
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 southern (SH) hemisphere influenza season.
Influenza A [A/Darwin/6/2021 (H3N2)-like virus] Neuraminidase (NA), His-tag
This recombinant neuraminidase protein is derived from the NA sequence of the Influenza A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. It was manufactured in mammalian HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 - 2023 northern hemisphere influenza season.
Influenza A [A/Darwin/9/2021 (H3N2)-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of A/Darwin/9/2021 (H3N2)-like virus, expressed and purified from HEK293 cells as (AA) 1-529 as a stable trimer and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Influenza A [A/Darwin/9/2021 (H3N2)-like virus] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of Influenza A/Darwin/9/2021 (H3N2)-like virus, expressed and purified from HEK293 cells as aa 18-545, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Influenza A [A/Duck/Egypt/AR526/2017] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Duck/Egypt/AR526/2017] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/Greylag_goose/England/054503/2021] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Greylag_goose/England/054503/2021] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/Greylag_goose/Scotland/024915/2022] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Greylag_goose/Scotland/024915/2022] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
![Influenza A [A/Guinea Fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/01/shutterstock_1181475319-300x300.jpg)
Influenza A [A/Guinea Fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin (HA), His-Tag
Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA) protein, comprising amino acids 17-531, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
![Influenza A [A/Guinea Fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1 (HA1), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/01/shutterstock_1202681137-300x300.jpg)
Influenza A [A/Guinea Fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1 (HA1), His-Tag
Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1(HA1) protein comprising amino acids 19-338, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of A/Hawaii/70/2019 (H1N1)pdm09-like virus, expressed and purified from HEK293 cells as aa 1-529, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-Tag
This Influenza virus neuraminidase protein is derived from the NA sequence of the A/Hawaii/70/2019 (H1N1)pdm09-like virus, expressing aa 46-469, and fused with a polyhistidine tag at the C-terminus. The influenza virus neuraminidase protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Hong Kong/1/1968 (H3N2)], Nucleoprotein (NP), His-Tag
Influenza A [A/Hong Kong/1/1968 (H3N2)] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli.
![Influenza A [A/Hong Kong/45/2019 (H3N2)]](https://thenativeantigencompany.com/wp-content/uploads/2020/12/Misc-Virus-122-300x300.jpg)
Influenza A [A/Hong Kong/45/2019 (H3N2)] Hemagglutinin (HA), His-Tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of Influenza A/Hong Kong/45/2019 (H3N2) expressing aa 18-529, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Hong Kong/45/2019 (H3N2)] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of A/Hong Kong/45/2019 (H3N2), expressed and purified from HEK293 cells as aa 31-468, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
![Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/1970/01/shutterstock_1204546204-300x300.jpg)
Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA), His-Tag
Recombinant Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) protein, comprising amino acids 17-531, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
Powered by Bioz